From late 2022 through 2025, RNDC lost several key suppliers that together accounted for more than $3 billion in annual revenue
For veterans with established cardiovascular disease or multiple risk factors, citing the SELECT trial outcomes directly supports the cardiovascular benefit argument [11]
It is one of the first randomized controlled trials to explore the safety and effectiveness of semaglutide in patients with schizophrenia, obesity, and prediabetesconditions that commonly overlap due to the metabolic side effects of second-generation antipsychotics
The medication's stability profile has been extensively studied, and degradation pathways generally result in inactive peptide fragments rather than harmful compounds
Using semaglutide as a crutch, not a catalyst While semaglutide helps reduce food noise and caloric intake, it's not a long-term replacement for building sustainable habits
Many patients seeking weight loss also use traditional herbs like moringa for its purported nutritional benefits, creating questions about safety and efficacy when these therapies overlap